Linkoping, Sweden-based digital health company Amra has raised $9 million in a round led Pfizer Venture Investments and Novo Seeds with participation from Industrifonden.
Founded in 2010, Amra measures body composition using a magnetic, cloud-based, computer-aided service. The technology collects data from a 6-minute MRI scan of the entire body and provides measurements of fat and muscle as they pertain to such areas as obesity, NAFLD/NASH, cardiovascular disease, diabetes, oncology, sarcopenia, cachexia, muscle disorders, rare diseases, and more. The company is beginning to move away from body mass index (BMI) and towards a more precise Body Composition Profile (BCP).
This technology has the potential to predict the risk a patient has of developing certain diseases, such as diabetes, cardiovascular disease, sarcopenia, and more. The service has received the CE mark for clinical use in Europe.
The company intends to use the investment to build its global presence and grow its network among researchers and pharmaceutical companies.
Read more: FinSMEs